Glycosylation of biotherapeutic proteins is frequently a critical quality attribute; therefore the characterization of glycans on biotherapeutics is an important activity in the development process. A common approach is to release and label N-glycans
with a tag to allow for fluorescence detection; a process that often requires numerous hours to complete. Unfortunately,
many of the most commonly used fluorescent tags have poor MS sensitivity.